[Cost effectiveness of clopidogrel in acute coronary syndromes without ST-elevation (unstable angina, non-Q AMI)].
Krisztina
K
Hagymási
D000208:Acute Disease; D000789:Angina, Unstable / Q000188:drug therapy* / Q000191:economics*; D002170:Canada; D002309:Cardiology; D000077144:Clopidogrel; D003226:Congresses as Topic; D003362:Cost-Benefit Analysis; D005602:France; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000191:economics*; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use; D012955:Societies, Medical; D013548:Sweden; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use; D006113:United Kingdom; D014481:United States
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine